Cargando…

Bioaccessibility In Vitro of Nutraceuticals from Bark of Selected Salix Species

The aim of this study was to investigate and to compare the extractability, bioaccessibility, and bioavailability in vitro of antioxidative compounds from bark of selected Salix species: S. alba (SA), S. daphnoides (SD), S. purpurea (SP), and S. daphnoides x purpurea (SDP) hybrid willow clones origi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawlik-Dziki, Urszula, Sugier, Danuta, Dziki, Dariusz, Sugier, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947866/
https://www.ncbi.nlm.nih.gov/pubmed/24696660
http://dx.doi.org/10.1155/2014/782763
_version_ 1782306724029399040
author Gawlik-Dziki, Urszula
Sugier, Danuta
Dziki, Dariusz
Sugier, Piotr
author_facet Gawlik-Dziki, Urszula
Sugier, Danuta
Dziki, Dariusz
Sugier, Piotr
author_sort Gawlik-Dziki, Urszula
collection PubMed
description The aim of this study was to investigate and to compare the extractability, bioaccessibility, and bioavailability in vitro of antioxidative compounds from bark of selected Salix species: S. alba (SA), S. daphnoides (SD), S. purpurea (SP), and S. daphnoides x purpurea (SDP) hybrid willow clones originating from their natural habitats and cultivated on the sandy soil. The highest amount of phenolic glycosides was found in the bark of SDP and SD. The best source of phenolics was bark of SDP. The highest content of flavonoids were found in SD bark samples, whereas the highest concentration of bioaccessible and bioavailable phenolic acids was determined in SDP bark. Bark of all tested Salix species showed significant antiradical activity. This properties are strongly dependent on extraction system and genetic factors. Regardless of Salix genotypes, the lowest chelating power was found for chemically-extractable compounds. Bark of all Salix species contained ethanol-extractable compounds with reducing ability. Besides this, high bioaccessibility and bioavailability in vitro of Salix bark phytochemicals were found. Obtained results indicate that extracts from bark tested Salix genotypes can provide health promoting benefits to the consumers; however, this problem requires further study.
format Online
Article
Text
id pubmed-3947866
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39478662014-04-02 Bioaccessibility In Vitro of Nutraceuticals from Bark of Selected Salix Species Gawlik-Dziki, Urszula Sugier, Danuta Dziki, Dariusz Sugier, Piotr ScientificWorldJournal Research Article The aim of this study was to investigate and to compare the extractability, bioaccessibility, and bioavailability in vitro of antioxidative compounds from bark of selected Salix species: S. alba (SA), S. daphnoides (SD), S. purpurea (SP), and S. daphnoides x purpurea (SDP) hybrid willow clones originating from their natural habitats and cultivated on the sandy soil. The highest amount of phenolic glycosides was found in the bark of SDP and SD. The best source of phenolics was bark of SDP. The highest content of flavonoids were found in SD bark samples, whereas the highest concentration of bioaccessible and bioavailable phenolic acids was determined in SDP bark. Bark of all tested Salix species showed significant antiradical activity. This properties are strongly dependent on extraction system and genetic factors. Regardless of Salix genotypes, the lowest chelating power was found for chemically-extractable compounds. Bark of all Salix species contained ethanol-extractable compounds with reducing ability. Besides this, high bioaccessibility and bioavailability in vitro of Salix bark phytochemicals were found. Obtained results indicate that extracts from bark tested Salix genotypes can provide health promoting benefits to the consumers; however, this problem requires further study. Hindawi Publishing Corporation 2014-02-17 /pmc/articles/PMC3947866/ /pubmed/24696660 http://dx.doi.org/10.1155/2014/782763 Text en Copyright © 2014 Urszula Gawlik-Dziki et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gawlik-Dziki, Urszula
Sugier, Danuta
Dziki, Dariusz
Sugier, Piotr
Bioaccessibility In Vitro of Nutraceuticals from Bark of Selected Salix Species
title Bioaccessibility In Vitro of Nutraceuticals from Bark of Selected Salix Species
title_full Bioaccessibility In Vitro of Nutraceuticals from Bark of Selected Salix Species
title_fullStr Bioaccessibility In Vitro of Nutraceuticals from Bark of Selected Salix Species
title_full_unstemmed Bioaccessibility In Vitro of Nutraceuticals from Bark of Selected Salix Species
title_short Bioaccessibility In Vitro of Nutraceuticals from Bark of Selected Salix Species
title_sort bioaccessibility in vitro of nutraceuticals from bark of selected salix species
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947866/
https://www.ncbi.nlm.nih.gov/pubmed/24696660
http://dx.doi.org/10.1155/2014/782763
work_keys_str_mv AT gawlikdzikiurszula bioaccessibilityinvitroofnutraceuticalsfrombarkofselectedsalixspecies
AT sugierdanuta bioaccessibilityinvitroofnutraceuticalsfrombarkofselectedsalixspecies
AT dzikidariusz bioaccessibilityinvitroofnutraceuticalsfrombarkofselectedsalixspecies
AT sugierpiotr bioaccessibilityinvitroofnutraceuticalsfrombarkofselectedsalixspecies